Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:919-924
Published online before print March 6, 2008, doi: 10.1161/ATVBAHA.108.162842
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Additional Materials
Right arrow All Versions of this Article:
28/5/919    most recent
ATVBAHA.108.162842v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rask-Madsen, C.
Right arrow Articles by King, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rask-Madsen, C.
Right arrow Articles by King, G. L.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:919.)
© 2008 American Heart Association, Inc.


Cell Biology and Signaling

Differential Regulation of VEGF Signaling by PKC-{alpha} and PKC-{epsilon} in Endothelial Cells

Christian Rask-Madsen; George L. King

From the Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Mass.

Correspondence to George L. King, MD, Joslin Diabetes Center, Harvard Medical School, One Joslin Place, Room 4504, Boston, MA 02215. E-mail george.king{at}joslin.harvard.edu

Objective— Vascular endothelial growth factor (VEGF) stimulates proangiogenic signal transduction and cell function in part through activation of protein kinase C (PKC). Our aim was to examine how individual isoforms of PKC affect VEGF action.

Methods and Results— Transfection of bovine aortic endothelial cells with small interfering RNA (siRNA) targeting either PKC-{alpha}, {delta}, or {epsilon} caused a reduction in the cognate PKC protein by 76% to 89% without changing expression of nontargeted isoforms. Downregulation of PKC-{epsilon} abrogated VEGF-stimulated phosphorylation of Akt at Ser473 and eNOS at Ser1179 and decreased VEGF-stimulated NO synthase activity in intact cells. In contrast, PKC-{alpha} knockdown increased Akt and eNOS phosphorylation, whereas PKC{delta} knockdown had no significant effect. PKC-{epsilon} knockdown also decreased VEGF-stimulated Erk1/2 phosphorylation and abolished VEGF-stimulated DNA synthesis. Consistent with an effect on several pathways of VEGF signaling, VEGF receptor-2 (VEGFR2) tyrosine phosphorylation and expression of VEGFR2 protein and mRNA was decreased by 81, 90, and 84%, respectively, during knockdown of PKC-{epsilon}, but increased during PKC-{alpha} knockdown.

Conclusions— By regulating VEGFR2 expression and activation, PKC-{epsilon} expression is critical for activation of Akt and eNOS by VEGF and contributes to VEGF-stimulated Erk activation, whereas PKC-{alpha} has opposite effects.

Downregulation of PKC{epsilon} with siRNA decreased Akt, eNOS, and Erk1/2 phosphorylation, NO synthase activity, and DNA synthesis stimulated by VEGF, likely through a dramatic decrease in VEGF receptor-2 (VEGFR2) tyrosine phosphorylation, and VEGFR2 protein and mRNA expression. In contrast, PKC-{alpha} knockdown increased VEGFR2 phosphorylation, VEGFR2 expression, and downstream signaling.


Key Words: endothelium vascular • vascular endothelial growth factor A • receptors vascular growth factor • nitric oxide synthase type III • protein kinase C




This article has been cited by other articles:


Home page
BloodHome page
M. Oubaha and J.-P. Gratton
Phosphorylation of endothelial nitric oxide synthase by atypical PKC{zeta} contributes to angiopoietin-1-dependent inhibition of VEGF-induced endothelial permeability in vitro
Blood, October 8, 2009; 114(15): 3343 - 3351.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. S. Rothmeier, I. Ischenko, J. Joore, D. Garczarczyk, R. Furst, C. J. Bruns, A. M. Vollmar, and S. Zahler
Investigation of the marine compound spongistatin 1 links the inhibition of PKC{alpha} translocation to nonmitotic effects of tubulin antagonism in angiogenesis
FASEB J, April 1, 2009; 23(4): 1127 - 1137.
[Abstract] [Full Text] [PDF]